查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190904

氟化物衍生物市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Fluorine Derivatives Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，氟衍生物市場的複合年增長率預計將超過 4%。

在 COVID-19 爆發期間，人們積極尋找有效且經濟的藥物來降低冠狀病毒疾病進展的風險。 針對 COVID-19 的氟化口服藥物，包括第一種治療 COVID-19 的口服片劑 Paxlovid，構成了一個重要的亞組。 氟化物衍生物廣泛用於製藥市場，可提高選擇性指數、增加親脂性、增加代謝穩定性並提高抗 COVID-19 功效。

主要亮點

  • 短期內，市場由對氟的高需求的大型工業驅動，氟比天然氣更輕且更具成本效益。 此外，六氟化鈾等終端用途的增加和氟化硫終端用途的增加預計將增加氟衍生物的全球消費量，從而導致市場增長。
  • 但是，據推測，由於氣體釋放在運輸過程中存在危險，氟衍生物的需求將很快減少。 此外，製造過程的複雜性可能會阻礙新進入者，減緩市場增長，並阻礙市場擴張。
  • 但是，研發活動在氟衍生物市場的增長中發揮著關鍵作用。 玩家參與這些活動以發現見解和處方。 這些配方有助於增加玩家收入，在某些情況下還有助於市場增長。
  • 在預測期內，預計北美將主導全球市場。

主要市場趨勢

醫藥行業需求旺盛

  • 4-Fluoro-3-chloroaniline 是一種有機氟化結構單元，用於合成藥物和生物活性化合物。 2,6-二氟苯甲□胺是一種灰白色粉末，用作合成苯甲□尿類殺蟲劑和醫藥化學品的重要中間體。
  • 根據世界銀行數據，全球醫藥製造業結構高度集中，美國企業相對較少，歐洲國家企業較少，印度和中國企業較少。
  • 阿斯利康表示，在需求大幅增長的推動下，2021 年 Covid 疫苗的銷售額將達到 1.186 萬億美元，與 2020 年的 11.01 億美元相比增長近 8%。
  • 美國的醫療保健和製藥行業是全球市場中最先進的行業之一。 根據醫療保險和醫療補助服務中心的數據，美國醫療保健支出在 2020 年增長了 9.7%，達到 4.1 萬億美元。 醫療保健支出約佔該國 GDP 的 19.7%。
  • 該國人均醫療費用的增加、醫療基礎設施的進步、保險政策的普及以及傳染病和慢性病的增加導致多次住院並獲得各種醫療服務和藥物。現在 為此，製藥應用□□對氟衍生物的需求也在增加。

北美主導市場

  • 北美在市場份額和市場收入方面主導著氟衍生物市場。 該地區將在預測期內繼續發揮其主導地位。
  • 氟衍生物在製藥和核燃料行業的使用增加將推動市場增長。
  • 不斷增長的醫療保健支出、政府對消費者整體健康的關注以及技術進步是推動北美氟衍生物市場規模增長的主要因素。
  • 北美最大的醫藥市場是美國。 美國約佔全球醫藥市場的 45% 和全球產量的約 22%。 由於免疫接種實踐以及對基本和非基本治療的需求增加，美國的藥品銷售和生產一直很強勁。
  • 這些因素正在推動市場增長。

競爭格局

氟衍生物市場是一個綜合性市場。 市場上的主要製造商包括 Thermo Fisher、VIO CHEMICALS、NINGBO INNO PHARMCHEM、Alchem Synthon Pvt, Ltd、石家莊 Old Bridge Chemicals Co. 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查先決條件
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 司機
    • 六氟化鈾等氟衍生物的最終用戶增加
    • 增加氟化硫的最終用途
  • 約束因素
    • 運輸過程中的危險
    • 複雜的製造過程阻礙了新進入者
  • 工業價值鏈分析
  • 波特的五力分析
    • 供應商的議價能力
    • 消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第 5 章市場細分

  • 導數
    • 3-氯-4-氟苯胺
    • 2,4-二氟芐胺
    • 2,6-二氟苯甲□胺
    • 2,4-二氟苯胺
    • 其他衍生物
  • 用法
    • 醫藥
    • 有機合成
    • 殺蟲劑
    • 其他用途
  • 按地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中東和非洲
      • 沙特阿拉伯
      • 南非
      • 其他中東和非洲地區

第六章競爭格局

  • 併購、合資企業、聯盟、合同
  • 市場份額 (%)**/排名分析
  • 主要參與者採用的策略
  • 公司簡介
    • Aarti Industries
    • Alchem Synthon Pvt. Ltd
    • Gujarat Fluorochemicals Limited（GFL）
    • Krishna Solvechem Ltd
    • Kingchem Life Science LLC
    • Merck KGaA
    • NINGBO INNO PHARMCHEM
    • Shijiazhuang Old Bridge Chemicals Co.
    • Thermo Fisher
    • VIO CHEMICALS

第七章市場機會與未來趨勢

  • 研發活動將在氟衍生物市場的發展中發揮重要作用
簡介目錄
Product Code: 92721

The fluorine derivatives market is expected to register a CAGR of over 4% during the forecast period of 2022-2027.

During the outbreak of COVID-19, the search for effective and economical drugs that would reduce the risk of progression of the coronavirus disease became abundantly clear. Fluorinated oral drugs against COVID-19, including Paxlovid, the first oral tablet to treat COVID-19, form an important subgroup. Fluorine derivatives are widely used in the pharmaceutical market and can lead to improved selectivity indices, increased lipophilicity, greater metabolic stability, and improved anti-COVID-19 efficacy.

Key Highlights

  • Over the short term, the market is driven by large industries as they have a high demand for fluorine, which is light and more cost-effective than gas. Furthermore, increasing end-users such as uranium hexafluoride and increasing end-use of sulfur fluoride are expected to increase the global consumption of fluorine derivatives, leading to market growth.
  • However, it is estimated that the demand for fluorine derivatives will decrease shortly due to the harmful hazardous effects during transportation if the gas is released. In addition, the complex manufacturing process discourages the entry of new entrants and is likely to slow down market growth and prevent market expansion.
  • Nevertheless, research and development activities play a significant role in the growth of the fluorine derivatives market. Players are engaged in these activities to discover insights and formulations. These formulations help increase the players' revenue and possibly contribute to market growth.
  • North America is expected to dominate the global market during the forecast period.

Key Market Trends

Booming Demand from the Pharmaceutical Segment

  • 4-Fluoro-3-chloroaniline is an organic fluorinated building block used to synthesize pharmaceutical and biologically active compounds. 2,6-Difluorobenzamide is an off-white powder used as an essential intermediate in synthesizing benzoylurea insecticides and pharmaceutical chemicals.
  • As per the World Bank data, the structure of the global pharmaceutical manufacturing industry is highly concentrated, with relatively few firms in United States, a handful in European countries, and a lesser extent in India and China.
  • According to AstraZeneca, covid vaccine sales in 2021 were USD 1,186 billion, an increase of almost 8% compared to the total of USD 1,101 billion in 2020, indicating a significant increase in demand.
  • The healthcare and pharmaceutical sector in United States is one of the most advanced sectors in the global market. According to the Centers for Medicare & Medicaid Services, the nation's healthcare spending grew 9.7% in 2020 to USD 4.1 trillion. Healthcare spending accounted for around 19.7% of the country's GDP.​
  • An increase in per capita health care expenditure, advancement in health infrastructure, availability of insurance policies, and increase in the number of infectious and chronic diseases in the country have led to the hospitalization of several patients and the use of various medical services and pharmaceutical drugs. This has also increased the demand for fluorine derivatives in pharmaceutical applications.​

North America Region to Dominate the Market

  • North America dominates the fluorine derivatives market in terms of market share and market revenue. The region is set to continue to flourish in its dominance over the forecast period.
  • The increasing use of fluorine derivatives in the pharmaceutical and nuclear fuels industries shall drive market growth.
  • The rise in healthcare expenditure, government focus on consumers' overall health, and technological advancement are the key factors driving the North American fluorine derivatives market size.
  • United States has the largest pharmaceutical market in North America. The country accounts for around 45% of the global pharmaceutical market and around 22% of global production. United States pharmaceutical sales and output remain robust due to the ongoing vaccinations and ramp-up demand for essential and non-essential medical treatments.
  • All the attributes mentioned above are likely to drive market growth.

Competitive Landscape

The fluorine derivatives market is consolidated in nature. Some of the major manufacturers in the market include Thermo Fisher, VIO CHEMICALS, NINGBO INNO PHARMCHEM, Alchem Synthon Pvt, Ltd., Shijiazhuang Old Bridge Chemicals Co., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing End-Users of Fluorine Derivatives such as Uranium Hexafluoride
    • 4.1.2 Increasing End-Use of Sulfur Fluoride
  • 4.2 Restraints
    • 4.2.1 Hazardous Effects During Transportation
    • 4.2.2 Complex Manufacturing Process Discourages the Entry of New Entrants
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Derivatives
    • 5.1.1 3-Chloro-4-Flouro Aniline
    • 5.1.2 2,4-Diflouro Benzylamine
    • 5.1.3 2,6-Diflouro Benzamide
    • 5.1.4 2,4-Difluoro Aniline
    • 5.1.5 Other Derivatives
  • 5.2 Applications
    • 5.2.1 Pharmaceutical
    • 5.2.2 Organic Synthesis
    • 5.2.3 Agrochemicals
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 France
      • 5.3.3.4 Italy
      • 5.3.3.5 Spain
      • 5.3.3.6 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis**
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Aarti Industries
    • 6.4.2 Alchem Synthon Pvt. Ltd
    • 6.4.3 Gujarat Fluorochemicals Limited (GFL)
    • 6.4.4 Krishna Solvechem Ltd
    • 6.4.5 Kingchem Life Science LLC
    • 6.4.6 Merck KGaA
    • 6.4.7 NINGBO INNO PHARMCHEM
    • 6.4.8 Shijiazhuang Old Bridge Chemicals Co.
    • 6.4.9 Thermo Fisher
    • 6.4.10 VIO CHEMICALS

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Research and Development Activities play a Significant Role in the Growth of the Fluorine Derivatives Market